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New Findings
 What is the central question of this study?
In humans, ‘Western-style’ diet is characterized by high levels of both saturated fats and
fructose. Lipid oversupply to the liver typical of high-fat diets could be exacerbated by the
coexistence of high levels of fat and fructose in the diet, thus accelerating the development of
metabolic deregulation.
 What is the main finding and its importance?
Short-term consumption of a Western diet, rich in saturated fats and fructose, is more
conducive to the development of liver steatosis and deleterious to glucose homeostasis than a
high-fat diet. This result points to the harmful effect of adding fructose to the usual Western,
high-fat diet.
The purpose of the present study was to examine the short-term effect of high-fat or
high-fat–high-fructose feeding on hepatic lipid metabolism and mitochondrial function in
adult sedentary rats. Adult male rats were fed a high-fat or high-fat–high-fructose diet for
2 weeks. Body and liver composition, hepatic steatosis, plasma lipid profile and hepatic insulin
sensitivity, together with whole-body and hepatic de novo lipogenesis, were assessed. Hepatic
mitochondrial mass, functionality, oxidative stress and antioxidant defense were alsomeasured.
Rats fed the high-fat–high-fructose diet exhibited significantly higher plasma triglycerides,
non-esterified fatty acids, insulin and indexes of hepatic insulin resistance compared with rats
fed a low-fat or a high-fat diet. Hepatic triglycerides and ceramide, as well as the degree of
steatosis and necrosis, were significantly higher, while liver p-Akt was significantly lower, in rats
fedhigh-fat–high-fructosediet than in rats fedhigh-fat diet.A significant increase innon-protein
respiratory quotient and hepatic fatty acid synthase and stearoyl CoA desaturase activity was
found in rats fed the high-fat–high-fructose diet compared with those fed the high-fat diet.
Significantly lower mitochondrial oxidative capacity but significantly higher oxidative stress
was found in rats fed high-fat and high-fat–high-fructose diets compared with rats fed low-fat
diet, while mitochondrial mass significantly increased only in rats fed high-fat–high-fructose
diet. In conclusion, short-termconsumptionof aWesterndiet, rich in saturated fats and fructose,
is more conducive to the development of liver steatosis and deleterious to glucose homeostasis
than a high-fat diet.
(Received 31 March 2014; accepted after revision 18 June 2014; first published online 27 June 2014)
Corresponding author S. Iossa: Department of Biology, Complesso Universitario di Monte Sant’Angelo, Edificio 7, Via
Cinthia – I-80126, Napoli, Italy. Email: susiossa@unina.it
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society DOI: 10.1113/expphysiol.2014.079632
1204 Exp Physiol 99.9 (2014) pp 1203–1213R. Crescenzo and others
Introduction
Chronic consumption of high-fat diets contributes to
the development of obesity and type 2 diabetes (Lanni
et al. 2005; Rutledge & Adeli, 2007; Qi et al. 2009).
In particular, we have previously shown that long-term
feeding with diets rich in fat causes the onset of
obesity, insulin resistance, liver lipid deposition and
mitochondrial derangement in a rat model of adult,
sedentary humans (Crescenzo et al. 2008). Interestingly,
a similar pattern of metabolic deregulation is evident
after long-term feeding with a low-fat diet rich in
fructose, a popular sugar used industrially to sweeten
foods and beverages (Crescenzo et al. 2013b). Behind
these similarities, however, high-fat and high-fructose
diets affect whole-body lipidmetabolism in differentways.
In fact, during high-fat feeding an increased lipid supply
to peripheral organs, and particularly to the liver, arises
mainly from dietary lipids, while during high-fructose
feeding an increased hepatic de novo lipogenesis is the
main source of circulating lipids (Ren et al. 2012).
In humans, consumption of a ‘Western-style diet’,
characterized by high levels of both saturated fats and
fructose, could favour the development of metabolic
diseases. In fact, it is possible that the deleterious effects
of fat or fructose found by us after long-term dietary
treatment (Crescenzo et al. 2008; Crescenzo et al. 2013b)
could be additive when high-fat–high-fructose diets are
consumed. In these condition, lipid oversupply to the
liver could be due to both dietary fats and hepatic
de novo lipogenesis and could, therefore, accelerate the
development of metabolic deregulation. In addition, the
putative lipid overflow to hepatic cells could influence
mitochondrial function.
Taking into account the above considerations, we
considered it to be of interest to evaluate hepatic
lipid metabolism and mitochondrial dysfunction in rats
fed a high-fat or high-fat–high-fructose diet, the latter
mimicking a typical unhealthy Western diet. Long-term
dietary treatment is not adequate to address this issue,
because high fat or high fructose alone each induces
metabolic derangement. Assessments were therefore
carried out after 2 weeks of dietary treatment, when
normal glucose tolerance ismaintained inhigh-fat-fed rats
(Iossa et al. 2003), so that the possible worsening effect of
adding fructose to the high-fat diet could be detected. The
results obtained provide evidence of the worsening effect
of fructose during short-term high-fat feeding on hepatic
insulin sensitivity and lipid metabolism.
Methods
Ethical approval
Treatment, housing and killing of rats met the guidelines
set by the Italian Health Ministry. All experimental
procedures involving rats were approved by ‘Comitato
Etico-Scientifico per la Sperimentazione Animale’ of the
University ‘Federico II’ of Naples.
Animals
Male Sprague–Dawley rats (Charles River, Lecco, Italy)
90 days of age were caged in a temperature-controlled
room (23 ± 1°C) with a 12 h–12 h light–dark cycle
(06.30–18.30 h light on) and divided into three groups
(each composed of six rats), which were fed the low-fat
(LF), high-fat (HF), or high-fat–high-fructose (HF-F)
diet for 2 weeks. All the rats were fed with the same
amount of calculated metabolizable energy (ME; 250 kJ),
corresponding to the amount of energy consumed by
the same rats immediately before the start of the dietary
regimen. The composition of the three diets is shown in
Table 1.
During the whole experimental period, faeces and
urine were collected daily and the respective energy
contents assessed with a bomb calorimeter. Daily food
consumption was monitored, gross energy density of
the diet was measured using the bomb calorimeter, and
gross energy intake was calculated. The ME intake was
determined by subtracting the energy measured in faeces
and urine from the gross energy intake. At the end of the
experimental period, the animals were anaesthesized with
zolazepamplus tiletamine (1:1) (30mgkg−1 I.P.) andkilled
by decapitation, the liver harvested, and the carcasses used
for determination of body composition.
Non-protein respiratory quotient (NPRQ)
The 24 h oxygen uptake, carbon dioxide output and
respiratory quotient of the rats were recorded with an
indirect open-circuit calorimeter (Panlab s.r.l., Cornella,
Barcelona, Spain). Urine was collected for the whole
period (24 h), and urinary nitrogen levels were measured
by an enzymatic colorimetric method (FAR S.r.l., Settimo
di Pescantina, Verona, Italy). The 24 h NPRQ was then
calculated.
Glucose tolerance test, plasma lipid profile and
hepatic transaminase
Rats were feed deprived for 6 h from 08.00 h. Basal
postabsorptive samples obtained from venous blood from
a small tail clip were collected in EDTA-coated tubes and
then glucose (2 g kg−1) was injected intraperitoneally.
Given that themagnitude of the rise in plasma glucose and
insulin concentrations immediately (0–30 min) following
the glucose load is proportional to the magnitude of
hepatic insulin resistance (Abdul-Ghani et al. 2007), and
the rise in plasma glucose and insulin concentrations can
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
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be quantified by the incremental area under the curve
(AUC) for plasma glucose and insulin, the product of
glucose AUC and insulin AUC during the first 30 min
after glucose load was calculated and used as an index of
hepatic insulin resistance.
After centrifugation at 1400ga for 8 min at 4°C,
plasma was removed and stored at −20°C until used
for determination of substrates and hormones. Plasma
glucose concentration was measured by a colorimetric
enzymatic method (Pokler Italia, Pontecagnano, Italy).
Plasma insulin concentration was measured using an
ELISA kit (Mercodia AB, Uppsala, Sweden) in a single
assay to avoid interassay variations. Basal postabsorptive
values of plasma glucose and insulin were used to calculate
the Homeostatic Model Assessment (HOMA) index as
[glucose (in milligrams per decilitre)] × [insulin (in
milliunits per litre)]/405 (Cacho et al. 2008).
Commercial kits adopting colorimetric enzymatic
methods were used to measure the plasma concentrations
of total cholesterol, triglycerides, alanine aminotransferase
(ALT; SGM Italia, Rome, Italy) and non-esterified fatty
acids (NEFAs; Randox Laboratories Ltd, Crumlin, Co.
Antrim, UK).
Body and liver composition
Body energy, lipid and protein content were measured as
previously described (Crescenzo et al. 2012). Briefly, the
alimentary tract was cleaned of undigested food and the
carcasses were then autoclaved. After dilution in distilled
water and subsequent homogenization of the carcasses,
duplicate samples of the homogenized carcass were
analysed for energy content by bomb calorimeter. Total
body lipids, as well as hepatic lipids, were measured by the
Folch extractionmethod (Folch et al. 1957). The energy as
lipid, calculated from body lipids by using the coefficient
of 39.2 kJ g−1, was then subtracted from total body energy
to obtain the energy as protein. Liver triglycerides and
cholesterol were measured by a colorimetric enzymatic
method using commercial kits (SGM Italia), and glycogen
was assessed by a direct enzymatic procedure (Roehrig &
Allred, 1974). Liver ceramide content was evaluated by
enzyme-linked immunosorbent assay (ELISA; Crescenzo
et al. 2013a).
Liver histology
Fragments of the liver of each animal with weights of1 g
were embedded inTissue-TekOCT(Sakura, Tokyo, Japan)
and stored at −80°C until sectioning. Frozen sections
of 10 μm thickness were obtained in a cryostat (JUNG
FRIGOCUT 2800N; Leica, Solms, Germany) and dried at
room temperature for 4 h. The sectionswere stained for 1 h
in a saturated solution of Sudan III in 70% ethanol, then
washed for 15 min in 50% ethanol and then in distilled
water. The sections were mounted in glycerol:PBS (9:1).
Ten digital images for each animal were analysed in
a random manner and studied to assess steatosis as
described by Catta-Preta et al. (2011). Software Image Pro
Plus, version 6.0.0.260 forWindows 2000/XP Professional
(Media Cybernetics, Rockville,MD,USA)was used for the
analyses (Fernandes-Santos et al. 2013).
Stearoyl CoA desaturase and fatty acid synthase
activity
Stearoyl CoA desaturase activity was measured
polarographically in liver homogenates at 37°C in a
solution containing 0.1 M K2HPO4, pH 7.4, 1 μM
myxothiazol, 0.12 mM NADH and 0.06 mM stearoyl-CoA
as the 5 mM cyanide-sensitive (Strittmatter et al. 1974),
myxothiazol-insensitive oxygen consumption. Fatty acid
synthase activity was measured in liver homogenates at
37°C by following the oxidation of 5 mg ml−1 NADPH in
a solution containing 0.1 M KH2PO4, pH 6.5, 1 mg ml−1
acetyl-CoA and 0.5mgml−1 malonyl-CoA (Penicaud et al.
1991).
Mitochondrial respiration
Isolation of liver mitochondria and measurement of
state 3 respiration were carried out as previously reported
(Crescenzo et al. 2012). Briefly, liver tissue fragments were
gently homogenized with a medium containing 220 mM
mannitol, 70 mM sucrose, 20 mM Hepes, 1 mM EDTA
and 0.1% (w/v) fatty acid-free bovine serum albumin,
pH 7.4, in a Potter Elvehjem homogenizer set at 500 r.p.m.
(4 strokes min−1). The homogenate was then centrifuged
at 1000ga for 10 min, and the resulting supernatant was
again centrifuged at 3000ga for 10min. Themitochondrial
pellet was washed twice and finally resuspended in a
medium containing 80 mM KCl, 50 mM Hepes, 5 mM
Tris-PO4, 1 mM EGTA and 0.1% (w/v) fatty acid-free
bovine serum albumin, pH 7.0. The oxygen consumption
rate was measured polarographically with a Clark-type
electrode (Yellow Springs Instruments, Yellow Springs,
OH, USA) in a 3 ml glass cell, at a temperature of 30°C in
a medium containing 80 mM KCl, 50 mM Hepes, 5 mM
K2HPO4, 1 mM EGTA and 0.1% (w/v) fatty acid-free
bovine serumalbumin,pH7.0.All sampleswere allowed to
oxidize their endogenous substrates for 3 min. Substrates
added were as follows: 10 mM glutamate plus 2.5 mM
malate; or 10 mM pyruvate plus 2.5 mM malate; or 40 μM
palmitoyl-coenzyme A plus 2 mM carnitine plus 2.5 mM
malate; or 10 mM succinate plus 3.75μM rotenone. State 3
oxygen consumption was measured in the presence of
0.3 mM ADP, while state 4 was obtained from oxygen
consumption measurements at the end of state 3, when
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
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ADP becomes limiting. The respiratory control ratio
(RCR) was calculated as the state 3/state 4 ratio.
Control experiments of enzymatic and electron
microscopy characterizationhave shown that our isolation
procedure (centrifugation at 3000ga for 10 min) results
in a cellular fraction that consists essentially of
mitochondria.
Mitochondrial lipid peroxidation, aconitase and
superoxide dismutase (SOD) specific activity
Lipid peroxidation was determined according to
Fernandes et al. (2006), by measuring thiobarbituric acid
reactive substances (TBARS), using the thiobarbituric acid
assay. Aliquots of mitochondrial suspensions were added
to 0.5 ml of ice-cold 40% trichloroacetic acid. Then, 2 ml
of 0.67% aqueous thiobarbituric acid containing 0.01% of
2,6-di-tert-butyl-p-cresol was added. The mixtures were
heated at 90°C for 15 min, then cooled in ice for 10 min,
and centrifuged at 850g for 10 min. The supernatant
fractions were collected, and lipid peroxidation was
estimated spectrophotometrically at 530 nm. The amount
of TBARS formed was calculated using a molar extinction
coefficient of 1.56 × 105 mol−1 cm−1 and expressed as
nanomoles of TBARS per milligram of protein.
Active aconitase specific activity was measured
spectrophotometrically by following the formation of
NADPH (340 nm) at 25°C in amixture containing 0.2mM
NADP+, 5 mM sodium citrate, 0.6 mM MnCl2, 2 U ml−1
final concentration of isocitric dehydrogenase, 50 mM
Tris–HCl, pH 7.4, and 30 ml of mitochondrial extract
(Gardner, 2002). Aconitase inhibited by reactive oxygen
species in vivo was reactivated so that total activity could
be measured by incubating mitochondrial extracts in a
medium containing 50 mM dithiothreitol, 0.2 mM Na2S
and 0.2 mM ferrous ammonium sulphate. The specific
activity of SOD was measured in a medium containing
0.1 mM EDTA, 2 mM KCN, 50 mM KH2PO4, pH 7.8,
20 mM cytochrome c, 0.1 mM xanthine and 0.01 U/ml
of xanthine oxidase. Determinations were carried out
spectrophotometrically (550 nm) at 25°C, by monitoring
the decrease in the reduction rate of cytochrome c by
superoxide radicals, generated by the xanthine–xanthine
oxidase system. One unit of SOD activity is defined as
the concentration of enzyme that inhibits cythocrome c
reduction by 50% in the presence of xanthine plus
xanthine oxidase (Flohe` & Otting, 1974).
Western blot quantification of mitochondrial
cytochrome c and hepatic Akt and p-Akt
In order to evaluate changes in liver mitochondrial
mass, the amount of a mitochondrial marker protein,
cytochrome c, was detected by Western blot. To this end,
tissue samples were denatured in a buffer (60.0 mM Tris,
pH6.8, 10%sucrose, 2%SDSand4%β-mercaptoethanol)
and loaded onto a 12% SDS-polyacrylamide gel. After the
run in electrode buffer (50 mM Tris, pH 8.3, 384 mM
glycine, 0.1% SDS), the gels were transferred onto
polyvinylidene fluoride membranes (Millipore, Billerica,
MA, USA) at 0.8 mA cm−2 for 90 min. The membranes
were preblocked in blocking buffer (PBS, 5%milk powder
and 0.5% Tween 20) for 1 h and then incubated overnight
at 4°Cwithmonoclonal antibody for cytochrome c (ENZO
Life Sciences, Farmingale, NY, USA; diluted 1:100 in
blocking buffer). Membranes were washed three times
for 12 min each time in PBS containing 0.5% Tween 20
and three times for 12 min in PBS; and then incubated
for 1 h at room temperature with an antimouse, alkaline
phosphatase-conjugated secondary antibody (Promega,
Madison, WI, USA). The membranes were washed as
described above, rinsed in distilled water and incubated
at room temperature with a chemiluminescent substrate,
CDP-Star (Sigma-Aldrich, St Louis, MO, USA). Data
detection was carried out by exposing autoradiography
films (Eastman Kodak Company, Rochester, NY, USA)
to the membranes. Quantification of signals was carried
out by Un-Scan-It gel software (Silk Scientific, Orem, UT,
USA). To normalize the specific signal of cytochrome c
in each lane, actin was detected as above using a
rabbit polyclonal antibody (Sigma-Aldrich) and an
antirabbit, alkaline phosphatase-conjugated secondary
antibody (Promega).
For p-Akt detection, an additional six rats for each
group were feed deprived for 6 h from 08.00 h, then
administered insulin (10 U kg−1) and killed 15 min
after insulin injection for Western blot analysis. Liver
tissue samples were treated as above and incubated with
polyclonal antibody for p-Akt (Cell Signaling, Danvers,
MA, USA; diluted 1:1000 in blocking buffer). Akt was
detected with polyclonal antibody (Cell Signaling; diluted
1:1000 in blocking buffer) andused to normalize the p-Akt
signal.
Statistical analysis
Data are given as means ± SEM. Statistical analyses
were performed by one-way ANOVA followed by Tukey’s
post hoc test. Probability values <0.05 were considered
to indicate a significant difference. All analyses were
performed using GraphPad Prism 4 (GraphPad Software,
San Diego, CA, USA).
Materials
All chemicals used were of analytical grade and were
purchased from Sigma (St Louis, MO, USA).
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
Exp Physiol 99.9 (2014) pp 1203–1213 1207High-fat–high-fructose diet and liver lipids
Table 1. Composition of diets
Component Low-fat diet High-fat diet High-fat–high-fructose diet
Total weight of the daily portion (g) 18.78 16.18 16.18
Of which:
Standard chow (g)∗ 4.21 4.21 4.21
Sunflower oil (g) 0.62 0.62 0.62
Casein (g) 2.34 2.34 2.34
Butter (g) — 2.07 2.07
Cornstarch (g) 8.41 3.74 —
Fructose (g) — — 3.74
AIN mineral mix (g) 2.00 2.00 2.00
AIN vitamin mix (g) 1.00 1.00 1.00
Choline (g) 0.10 0.10 0.10
Methionine (g) 0.10 0.10 0.10
Metabolizable energy content of the daily portion (kJ)† 250 250 250
Protein [J (100 J)−1] 20.85 20.87 20.87
Lipids [J (100 J)−1] 11.29 42.53 42.53
Carbohydrates [J (100 J)−1] 67.86 36.60 36.60
Of which:
Fructose — — 25.00
Starch 67.86 36.60 11.60
SFA (%) 13.4 52.9 52.9
UFA (%) 86.6 47.1 47.1
MUFA (%) 33.4 30.1 30.1
PUFA (%) 53.2 17.0 17.0
UFA/SFA 6.5 0.9 0.9
∗Mucedola 4RF21 (Settimo Milanese, Milan, Italy) containing (in g kg−1): protein, 185; lipid, 30; and fibre, 60; metabolizable
energy 11.20 kJ g−1. †Estimated by computation using values (in kJ g−1) for energy content as follows: protein, 16.736; lipid,
37.656; and carbohydrate, 16.736. Abbreviations: AIN, American Institute of Nutrition; MUFA, monounsaturated fatty acids; PUFA,
polyunsaturated fatty acids; SFA, saturated fatty acids; UFA, unsaturated fatty acids.
Results
Body and liver composition, plasma parameters and
de novo lipogenesis
The HF and HF-F rats exhibited a significant increase in
body energy, body lipids and epididymal fat in comparison
to LF rats (Table 2), although the three groups of rats
exhibited similar ME intake (LF, 3412 ± 211 kJ; HF,
3392 ± 189 kJ; and HF+F, 3453 ± 223 kJ). In addition, in
HF-F rats, epididymal fat increased significantly compared
with HF rats.
Regarding liver composition, HF rats exhibited a
significant decrease in liver glycogen compared with LF
rats, while in HF-F rats the hepatic glycogen content was
similar to that found in LF rats and significantly higher
compared with HF rats (Table 2). A significant increase
in hepatic lipids, triglycerides and cholesterol was found
in HF and HF-F rats compared with LF rats. A further
increase was found in hepatic lipids and triglycerides
in HF-F rats compared with HF rats. Higher hepatic
ceramide content was found in HF-F rats compared with
LF and HF rats (Table 2). The degree of hepatic steatosis
was significantly higher in HF and HF-F rats compared
with LF rats (+152 and +577%, respectively), and a
significant increase was also evident when HF-F rats were
compared with HF rats (+168%) (Fig. 1). In addition,
plasma levels of ALT, considered to provide a reliable
index of hepatocellular necrosis (Ozera et al. 2008), were
significantly higher in HF-F rats compared with LF and
HF rats (Table 2).
The plasma lipid profile (Table 2) indicates a significant
increase in total cholesterol and NEFA in HF and HF-F
rats compared with LF rats. The HF-F rats exhibited
significantly higher triglycerides compared with LF and
HF rats, and NEFA exhibited a further significant
increase compared with HF rats. The NPRQ, an index of
whole-body de novo lipogenesis, was significantly lower
in HF rats than in LF rats, while in HF-F rats it was
significantly lower than in LF rats, but significantly higher
than in HF rats (Table 2). These data suggest an inhibition
of whole-body de novo lipogenesis induced by high-fat
diet,which is partly removedby fructose supplementation.
This picture is substantially confirmedby the evaluation
of hepatic lipogenic capacity, carried out by the assessment
of two rate-limiting enzymes, namely fatty acid synthase
and stearoyl CoA desaturase (Table 2). The results show
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
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Table 2. Whole-body and liver composition, plasma lipid profile and de novo lipogenesis in rats fed a low-fat, a high-fat or a
high-fat–high-fructose diet for 2 weeks
Parameter Low-fat diet High-fat diet High-fat–high-fructose diet
Final body weight (g) 492 ± 14 506 ± 17 507 ± 18
Body lipids [g (100 g bwt)−1] 12.6 ± 0.4 14.3 ± 0.4∗ 14.7 ± 0.5∗
Epididymal fat weight [g (100 g bwt)−1] 1.00 ± 0.10 1.28 ± 0.11∗ 1.69 ± 0.12∗∗ †
Epididymal fat weight [g (100 g lipids)−1] 7.9 ± 0.2 8.9 ± 0.2 11.5 ± 0.1∗∗∗∗ ††††
Body proteins [g (100 g bwt)−1] 16.1 ± 0.6 15.9 ± 1.3 15.9 ± 0.8
Body energy (kJ g−1) 8.7 ± 0.1 9.3 ± 0.1∗ 9.5 ± 0.2∗∗
Liver lipids (mg g−1) 51.2 ± 3.0 63.7 ± 3.0∗ 78.3 ± 3.0∗∗∗∗ ††
Liver triglycerides (mg g−1) 20.4 ± 2.0 38.6 ± 2.0∗∗∗∗ 52.5 ± 2.0∗∗∗∗ †††
Liver cholesterol (mg g−1) 3.7 ± 0.3 5.7 ± 0.3∗ 5.6 ± 0.7∗
Liver ceramide (AU g−1) 367 ± 21 350 ± 23 446 ± 20∗ †
Liver glycogen (mg g−1) 28.5 ± 2 22.5 ± 1.2∗ 26.6 ± 1.6†
Liver ALT (U l−1) 13.3 ± 1.0 12.4 ± 1.0 20.0 ± 1.1∗∗∗ †††
Plasma triglycerides [mg (100 ml)−1] 126 ± 4 125 ± 5 144 ± 5∗ †
Plasma cholesterol [mg (100 ml)−1] 51 ± 2 65 ± 2∗∗∗ 72 ± 2∗∗∗∗
Plasma NEFA (mM) 0.27 ± 0.02 0.43 ± 0.03∗ 0.66 ± 0.09∗∗∗ †
Non-protein respiratory quotient 1.10 ± 0.03 0.86 ± 0.03∗∗∗ 0.98 ± 0.03∗ †
Hepatic fatty acid synthase specific
activity [μU min−1 (mg protein)−1]
0.23 ± 0.03 0.14 ± 0.01∗ 0.29 ± 0.02†††
Hepatic stearoyl-CoA desaturase specific
activity [ng atoms oxygen min−1 (g
tissue)−1]
703 ± 25 293 ± 18∗∗∗∗ 393 ± 22∗∗∗∗ †
Values are the means ± SEM of six rats. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001 compared with low-fat diet; †P < 0.05,
††P< 0.01, †††P< 0.001, ††††P< 0.0001 compared with high-fat diet (one-way ANOVA followed by Tukey’s post hoc test). Abbreviations:
ALT, alanine aminotransferase; AU, absorbance unit; NEFA, non-esterified fatty acids; and U, unit.
a significant decrease in fatty acid synthase activity in HF
rats compared with LF rats, and a significant increase in
fatty acid synthase activity in HF-F rats compared with
HF rats. Stearoyl CoA desaturase activity was significantly
lower in HF and HF-F rats compared with LF rats, but
significantly higher in HF-F rats compared with HF rats
(Table 2).
Glucose homeostasis
Significantly higher plasma insulin and HOMA index
values were found in HF-F rats, in comparison to LF and
HF rats (Fig. 2A). In addition, hepatic insulin resistance
index, calculated during the early phase of the glucose
tolerance test, was found to be significantly higher inHF-F
rats compared with LF and HF rats (Fig. 2B). Hepatic
insulin sensitivity was also assessed by determining the
degree of phosphorylation of the kinase Akt, a distal
effector of insulin signalling, which was found to be
significantly lower in HF-F compared with LF and HF
rats (Fig. 2C).
Mitochondrial compartment
State 3 and state 4 oxidative capacity assessed in isolated
livermitochondria was found to be significantly decreased
in HF and HF-F rats compared with LF rats (Fig. 3A
and B), while no variation was evident in RCR values
(Fig. 3C). Whole-tissue cytochrome c/actin ratio, an
index of hepatic mitochondrial mass, was found to be
significantly increased inHF-F rats compared with LF and
HF rats (Fig. 3D and E). Lipid peroxidation and aconitase
specific activity were taken as an index of lipid and protein
oxidative damage, respectively (Table 3). A significant
increase in lipid peroxidation and a significant decrease
in active/total aconitase ratio were found in HF and HF-F
rats compared with LF rats. No significant variation was
found in SOD activity, taken as an index of mitochondrial
antioxidant defence (Table 3).
Discussion
Here we show that short-term combined effects of dietary
fat and fructose, in quantities that mimic a Western diet,
are similar to those induced by high-fat diet alone, i.e.
increased body energy and lipid content. From these
results, it appears that the supplementation with fructose
does not worsen the deleterious effects of high-fat feeding
on whole-body composition, at least after short-term
dietary treatment. In contrast, high-fat–high-fructose
diet worsens plasma lipid profile, by increasing circulating
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
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Table 3. Hepatic mitochondrial oxidative status in rats fed a low-fat, a high-fat or high-fat–high-fructose diet for 2 weeks
Parameter Low-fat diet High-fat diet High-fat–high-fructose diet
Active aconitase [mU (mg protein)−1] 7.6 ± 0.5 5.8 ± 0.5∗ 4.9 ± 0.3∗∗
Total aconitase [mU (mg protein)−1] 15.7 ± 0.8 17.6 ± 0.8 13.8 ± 1.0
Active aconitase/total aconitase 0.49 ± 0.02 0.33 ± 0.02∗∗∗ 0.36 ± 0.02∗∗∗
Lipid peroxidation [nmol (mg protein)−1] 1.36 ± 0.10 1.78 ± 0.10∗ 1.77 ± 0.10∗
Superoxide dismutase specific activity [U (mg protein)−1] 172 ± 10 163 ± 14 176 ± 15
Values are the means ± SEM of six rats. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 compared with low-fat diet (one-way ANOVA followed by
Tukey’s post hoc test).
lipids, in the form of triglycerides and NEFA. The
increased triglyceride plasma levels of HF-F rats are
very likely to reflect the increased lipid synthesis in the
liver dictated by high fructose intake. In agreement,
we show an inhibition of de novo lipogenesis at the
whole-body and liver level in HF rats, while de novo
lipogenesis is stimulated at the whole-body and liver
level in HF-F rats. This increased lipid synthesis could
be due to the hyperinsulinaemic condition of the HF-F
rats, because insulin is able to stimulate the pathway of
de novo lipogenesis, even in conditions of hepatic insulin
resistance (Choi & Ginsberg, 2011).
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Figure 1. Liver sections from rats fed a low-fat (A), a high-fat (B) or high-fat–high-fructose diet (C) for 2
weeks were stained with Sudan III, and 10 digital images per animal were analysed in a randommanner
for quantitative assessment (means ± SEM) of steatosis (D)
∗P< 0.05, ∗∗∗∗P< 0.0001 comparedwith low fat, ††††P< 0.0001 comparedwith high fat (one-way ANOVA
followed by Tukey’s post hoc test).
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It should be noted that here short-term high-fat
feeding is associated with an increase in circulating NEFA
in the absence of signs of hepatic insulin resistance, while
in previous studies we have found that after long-term
high-fat feeding, higher plasmaNEFAs are associated with
insulin resistance (Lionetti et al. 2007; Crescenzo et al.
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Figure 2. Plasma glucose and insulin (A), homeostasis model
assessment (HOMA) index and hepatic insulin resistance index
(B) and p-Akt/Akt ratio (C) in rats fed a low-fat, a high-fat or
high-fat–high-fructose diet for 2 weeks
Values are the means ± SEM of six rats. ∗∗P < 0.01,
∗∗∗∗P < 0.0001 compared with low fat; †P < 0.05,
††††P < 0.0001 compared with high fat (one-way ANOVA
followed by Tukey’s post hoc test).
2008). It can be hypothesized, therefore, that increased
plasma NEFAs contribute to the development of hepatic
insulin resistance during high-fat feeding, while the
consumption of a high-fat–high-fructose diet accelerates
the development of metabolic disturbances elicited by
high-fat feeding, as indicated by a further increase in
plasma NEFAs. In addition, in HF-F rats, we found an
increased HOMA index and hepatic insulin resistance
index, together with a decreased p-Akt/Akt ratio and
increased glycogen content. These variations are indicative
of hepatic insulin resistance in HF-F rats. In fact, indexes
derived from measurements of fasting plasma glucose
and insulin concentrations, such as the HOMA index,
primarily reflect hepatic insulin resistance (Abdul-Ghani
et al. 2007), because in the postabsorptive state80–85%
of glucose originates in the liver, so that the higher
the rate of glucose production and the plasma insulin
concentration, the greater the severity of hepatic insulin
resistance (Abdul-Ghani et al. 2007). In addition, during
the first 30 min after oral glucose load, the rise in plasma
glucose and insulin concentrations is proportional to the
magnitude of hepatic insulin resistance (Abdul-Ghani
et al. 2007). In the liver, insulin resistance usually refers
to the impaired ability of insulin to suppress hepatic
glucose production (Farese et al. 2012), so that hepatic
glycogen content can be considered an indirect index
of insulin failure. Finally, the insulin-stimulated signal
transduction pathway that suppresses hepatic glucose
production includes Akt, which is phosphorylated upon
stimulation by insulin, so that the relative amount of
p-Akt is a further indication of the insulin sensitivity of the
tissue.
It can be suggested that the higher plasma NEFAs
found in HF-F rats impair hepatic glucose homeostasis,
thus accelerating the effects we observed previously after
long-term high-fat feeding (Lionetti et al. 2007; Crescenzo
et al. 2008). In fact, the increased availability of fatty acids
in the form of plasma NEFA, found in HF and HF-F
rats, implies higher lipid flow to tissues, such as liver and
skeletal muscle. If this increased fatty acid availability is
in excess compared with the cellular oxidation capacity,
it could give rise to ectopic lipid deposition, one of the
main factors in the onset of insulin resistance (Carobbio
et al. 2011). To address this issue, we evaluated hepatic
deposition of lipids and found that the triglyceride content
in the liver paralleled the NEFA plasma levels. In fact,
increased hepatic triglycerides were found in HF rats,
and a further increase was evident in HF-F rats, coupled
with a significant increase in liver ceramide. Thus, we can
hypothesize that the onset of hepatic insulin resistance in
HF-F rats arises from increased hepatic triglyceride and
ceramide content.
The issue of mitochondrial adaptations to changes in
fuel supply is crucial in understanding the events leading
to cellular insulin resistance. In addition, it is a matter of
C© 2014 The Authors. Experimental Physiology C© 2014 The Physiological Society
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debatewhether the impairment ofmitochondrial function
precedes, and could thus be a cause of, the onset of insulin
resistance. We were therefore interested in assessing the
possible alterations in hepatic mitochondrial function at
an early stage of high-fat feeding, when insulin sensitivity
is maintained, and to verify the impact of fructose on
mitochondrial compartment. From our results, it appears
that hepatic mitochondrial impairment is an early event
induced by increased lipid content of the diet, because
it is already evident after 2 weeks of dietary treatment,
and that the presence of fructose does not have a
further impactonmitochondrial function. In addition, the
impairment occurs both in HF rats, with normal hepatic
insulin sensitivity, and in HF-F rats, with altered hepatic
insulin sensitivity, and it can therefore be suggested that
mitochondrial alterations precede, and could potentially
contribute to, hepatic insulin resistance.
In agreement with this suggestion, it has been shown
that enhancement of hepatic mitochondrial fatty acid
oxidation capacity is able to reverse insulin resistance
in mice fed a high-fat–high-fructose diet (Monse´ne´go
et al. 2012). The events linkingmitochondrial impairment
to insulin resistance could be a reduced capacity to
cope with the increased lipid supply to hepatocytes, thus
giving rise to lipotoxicity. In this respect, the increased
mitochondrial mass could be a compensatory response to
decreased oxidative capacities found in HF-F rats in order
to counteract elevated fatty acid substrate availability.
However, it is alsopossible thatmitochondrial impairment
could contribute to insulin resistance through increased
oxidative stress, a factor commonly considered important
in this condition (Rains & Jain, 2011), because increased
oxidative stress is evident in liver mitochondria from HF
and HF-F rats. The present data are also in line with the
postulated importance of lipid availability in the onset of
insulin resistance (Oakes et al. 2013), because, with the
same alteration in the mitochondrial oxidative capacity,
thehigherplasmaNEFA levels found inHF-F rats probably
worsen lipid overflow to liver cells, increasing ectopic
deposition.
In conclusion, we provide evidence that short-term
consumption of a typical Western diet, rich in saturated
fats and fructose, is more deleterious than a high-fat diet
for hepatic lipid metabolism and glucose homeostasis.
These results indicate the harmful effect of adding fructose
to the usual Western, high-fat diet.
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Figure 3. Hepatic mitochondrial state 3 (A) and state 4 respiratory capacities (B), respiratory control
ratios (C) and cytochrome c content (D) with representative Western blots (E) in rats fed a low-fat, a
high-fat or a high-fat–high-fructose diet for 2 weeks
Values are the means ± SEM of six rats. ∗P < 0.05, ∗∗∗P < 0.001 compared with low fat; ††††P < 0.0001
compared with high fat (one-way ANOVA followed by Tukey’s post hoc test).
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